Literature DB >> 11872904

Protective vasomotor effects of in vivo recombinant endothelial nitric oxide synthase gene expression in a canine model of cerebral vasospasm.

Vini G Khurana1, Leslie A Smith, Timothy A Baker, Daihiko Eguchi, Timothy O'Brien, Zvonimir S Katusic.   

Abstract

BACKGROUND AND
PURPOSE: Post-subarachnoid hemorrhage (SAH) cerebral vasospasm is a potentially devastating condition whose pathogenesis involves impaired nitric oxide (NO) bioavailability. We aimed to determine whether recombinant endothelial NO synthase (eNOS) gene expression may protect vasomotor function and prevent vasospasm in a canine experimental SAH model.
METHODS: Recombinant adenoviral vectors (5x10(9) plaque-forming units/animal) encoding genes for eNOS (AdeNOS) and beta-galactosidase (AdLacZ) or vehicle were injected into the cerebrospinal fluid (CSF) of dogs on day -1 (ie, 24 hours before the first intra-CSF injection of blood on day 0). Cerebral angiography was performed at day 0 (baseline) and day 7 (immediately before death), and tissues were harvested for additional studies.
RESULTS: Western analysis and immunohistochemistry detected recombinant eNOS exclusively in cerebral arteries isolated from AdeNOS-transduced dogs, and in this group of animals CSF NO concentrations were significantly elevated by day 2. Analysis of day 7 versus day 0 cerebral angiograms for each group revealed significant spasm at the basilar artery midpoint in AdLacZ-transduced and nontransduced dogs but not in AdeNOS-transduced dogs. Isometric force recording of basilar arteries isolated from AdeNOS-transduced dogs showed significantly augmented relaxations to bradykinin and reduced contractions to endothelin-1.
CONCLUSIONS: Our results suggest that expression of recombinant eNOS in the adventitia of cerebral arteries may contribute toward protection against post-SAH vasospasm.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11872904     DOI: 10.1161/hs0302.103735

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  10 in total

1.  mRNA expression in rabbit experimental aneurysms: a study using gene chip microarrays.

Authors:  W I Mangrum; F Farassati; R Kadirvel; C P Kolbert; S Raghavakaimal; D Dai; Y H Ding; D Grill; V G Khurana; D F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2007-05       Impact factor: 3.825

Review 2.  Gene therapy for cerebral vascular disease: update 2003.

Authors:  Kazunori Toyoda; Yi Chu; Donald D Heistad
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

Review 3.  Genetic determinants of cerebral vasospasm, delayed cerebral ischemia, and outcome after aneurysmal subarachnoid hemorrhage.

Authors:  Andrew F Ducruet; Paul R Gigante; Zachary L Hickman; Brad E Zacharia; Eric J Arias; Bartosz T Grobelny; Justin W Gorski; Stephan A Mayer; E Sander Connolly
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-13       Impact factor: 6.200

Review 4.  Relationship between endothelial nitric oxide synthase (eNOS) and natural history of intracranial aneurysms: meta-analysis.

Authors:  Eric Homero Albuquerque Paschoal; Vitor Nagai Yamaki; Renan Kleber Costa Teixeira; Fernando Mendes Paschoal Junior; Glaucia Suzanna Jong-A-Liem; Manoel Jacobsen Teixeira; Elizabeth Sumi Yamada; Ândrea Ribeiro-Dos-Santos; Edson Bor-Seng-Shu
Journal:  Neurosurg Rev       Date:  2016-06-23       Impact factor: 3.042

5.  Endothelial nitric oxide synthase gene single-nucleotide polymorphism predicts cerebral vasospasm after aneurysmal subarachnoid hemorrhage.

Authors:  Robert M Starke; Grace H Kim; Ricardo J Komotar; Zachary L Hickman; Eric M Black; Maritza B Rosales; Christopher P Kellner; David K Hahn; Marc L Otten; John Edwards; Tao Wang; James J Russo; Stephan A Mayer; Edward S Connolly
Journal:  J Cereb Blood Flow Metab       Date:  2008-03-05       Impact factor: 6.200

6.  MEL Ameliorates Post-SAH Cerebral Vasospasm by Affecting the Expression of eNOS and HIF1α via H19/miR-138/eNOS/NO and H19/miR-675/HIF1α.

Authors:  Guoqiang Hou; Hongjin Chen; Yuhua Yin; Yaohua Pan; Xiaohua Zhang; Feng Jia
Journal:  Mol Ther Nucleic Acids       Date:  2019-12-14       Impact factor: 8.886

7.  Concentrations of estradiol, progesterone and testosterone in sefrum and cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage correlate weakly with transcranial Doppler flow velocities.

Authors:  Jan Martin; Eva Plank; Bernhard Ulm; Jens Gempt; Maria Wostrack; Bettina Jungwirth; Simone M Kagerbauer
Journal:  BMC Neurosci       Date:  2021-04-23       Impact factor: 3.288

8.  Genetics of cerebral vasospasm.

Authors:  Travis R Ladner; Scott L Zuckerman; J Mocco
Journal:  Neurol Res Int       Date:  2013-04-11

9.  Nitric oxide in cerebral vasospasm: theories, measurement, and treatment.

Authors:  Michael Siuta; Scott L Zuckerman; J Mocco
Journal:  Neurol Res Int       Date:  2013-06-25

10.  Progesterone attenuates experimental subarachnoid hemorrhage-induced vasospasm by upregulation of endothelial nitric oxide synthase via Akt signaling pathway.

Authors:  Chia-Mao Chang; Yu-Feng Su; Chih-Zen Chang; Chia-Li Chung; Yee-Jean Tsai; Joon-Khim Loh; Chih-Lung Lin
Journal:  Biomed Res Int       Date:  2014-05-13       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.